[1] |
周小兵, 李玉鑫, 高方媛, 等. 肝硬化合并自发性细菌性腹膜炎133例的危险因素分析[J]. 中华消化杂志,2019,39(4):268-270.
|
[2] |
De Vaca RPC, Vairappan B, Espinoza TC, et al. Spontaneous bacterial peritonitis: physiopathological mechanism and clinical manifestations[J]. Adv Hepatol,2021:175-189.
|
[3] |
Hasa E, Hartmann P, Schnabl B. Liver cirrhosis and immune dysfunction[J]. Int Immunol,2022,34(9):455-466.
|
[4] |
Philips CA, Schnabl B, Bajaj JS. Gut microbiome and alcohol-associated liver disease[J]. J Clin Exp Hepatol,2022,12(5):1349-1359.
|
[5] |
Muñoz L, Borrero MJ, Úbeda M, et al. Intestinal immune dysregulation driven by dysbiosis promotes barrier disruption and bacterial translocation in rats with cirrhosis[J]. Hepatology, 2019,70(3):925-938.
|
[6] |
Du Plessis J, Vanheel H, Janssen CEI, et al. Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function[J]. J Hepatol,2013,58(6):1125-1132.
|
[7] |
Dever JB, Sheikh MY. spontaneous bacterial peritonitis-bacteriology, diagnosis, treatment, risk factors and prevention[J]. Aliment Pharmacol Ther,2015,41(11):1116-1131.
|
[8] |
Márquez M, Fernández-Gutiérrez C, Montes-de-Oca M, et al. Chronic antigenic stimuli as a possible explanation for the immunodepression caused by liver cirrhosis[J]. Clin Exp Immunol,2009,158(2):219-229.
|
[9] |
Dahabra L, Kreidieh M, Abureesh M, et al. Proton pump inhibitors use and increased risk of spontaneous bacterial peritonitis in cirrhotic patients: A retrospective cohort analysis[J]. Gastroenterology Res,2022,15(4):180-187.
|
[10] |
Charles J, Di Domizio J, Salameire D, et al. Characterization of circulating dendritic cells in melanoma: role of CCR6 in plasmacytoid dendritic cell recruitment to the tumor[J]. J Invest Dermatol,2010, 130(6):1646-1656.
|
[11] |
姜钰, 王蓓蓓, 孔雅娴, 等. 多色流式细胞术检测CHB患者外周血多重细胞因子分泌的Th细胞亚群[J/CD]. 中国肝脏病杂志(电子版),2017,9(4):43-48.
|
[12] |
Becht E, McInnes L, Healy J, et al. Dimensionality reduction for visualizing single-cell data using UMAP[J]. Nat Biotechnol,2019, 37(1):38-44.
|
[13] |
European Association For The Study Of The Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis[J]. J Hepatol,2010,53(3):397-417.
|
[14] |
Tinago W, Coghlan E, Macken A, et al. Clinical, immunological and treatment-related factors associated with normalised CD4+/CD8+ T-cell ratio: effect of naive and memory T-cell subsets[J]. PLoS One,2014, 9(5):e97011.
|
[15] |
宋洋子, 孔雅娴, 郝禹, 等. 十色流式检测HIV/AIDS患者外周血中T淋巴细胞亚群及活化状态[J/CD]. 中华实验和临床感染病杂志(电子版),2018,12(1):28-34.
|
[16] |
Kobak D, Linderman GC. Initialization is critical for preserving global data structure in both t-SNE and UMAP[J]. Nat Biotechnol, 2021,39(2):156-157.
|
[17] |
Yang Y, Sun H, Zhang Y, et al. Dimensionality reduction by UMAP reinforces sample heterogeneity analysis in bulk transcriptomic data[J]. Cell Rep,2021,36(4):109442.
|
[18] |
Kobak D, Linderman GC. UMAP does not preserve global structure any better than t-SNE when using the same initialization[J]. Bio Rxiv,2019,2019:877522.
|
[19] |
Jenne CN, Kubes P. Immune surveillance by the liver[J]. Nat Immunol,2013,14(10): 996-1006.
|
[20] |
Gao B, Jeong W I, Tian Z. Liver: an organ with predominant innate immunity[J]. Hepatology,2008,47(2):729-736.
|
[21] |
Irvine KM, Ratnasekera I, Powell EE, et al. Causes and consequences of innate immune dysfunction in cirrhosis[J]. Front Immunol, 2019,10:293.
|
[22] |
Albillos A, Lario M, Álvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance[J]. J Hepatol, 2014,61(6):1385-1396.
|
[23] |
Zhang Q, He Y, Luo N, et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma[J]. Cell,2019,179(4):829-845. e20.
|
[24] |
Nakano M, Ito M, Tanaka R, et al. PD-1+ TIM-3+ T cells in malignant ascites predict prognosis of gastrointestinal cancer[J]. Cancer Sci, 2018,109(9):2986-2992.
|
[25] |
Jiang X, Liu G, Li Y, et al. Immune checkpoint: The novel target for antitumor therapy[J]. Genes Dis,2021,8(1):25-37.
|
[26] |
Pulko V, Davies JS, Martinez C, et al. Human memory T cells with a naive phenotype accumulate with aging and respond to persistent viruses[J]. Nat Immunol,2016,17(8):966-975.
|
[27] |
Marrella V, Facoetti A, Cassani B. Cellular senescence in immunity against infections[J]. Int J Mol Sci,2022,23(19):11845.
|
[28] |
Cibrián D, Sánchez-Madrid F. CD69: from activation marker to metabolic gatekeeper[J]. Eur J Immunol,2017,47(6):946-953.
|
[29] |
You Z, Li Y, Wang Q, et al. The clinical significance of hepatic CD69+CD103+CD8+ resident-memory T cells in autoimmune hepatitis[J]. Hepatology,2021,74(2):847-863.
|